Status:
WITHDRAWN
Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)
Lead Sponsor:
Merck Sharp & Dohme LLC
Collaborating Sponsors:
Fulford India Limited
Conditions:
Pyoderma
Eligibility:
All Genders
6+ years
Phase:
PHASE4
Brief Summary
This open-label, randomized, parallel-group clinical study is designed to compare the efficacy and safety of the topical antibiotic, sisomicin cream, with that of another topical antibiotic cream, nad...
Eligibility Criteria
Inclusion
- Patients of either sex and suffering from primary pyodermas requiring topical antibiotic therapy without occlusive dressings.
- \>=6 years of age.
- Written informed consent.
Exclusion
- Patients must not take any other antibiotics.
- Patients should not be hypersensitive to any of the test drugs.
- Patients are not to have any other investigational drug within one month of starting this study.
- Patients cannot be enrolled more than once in the study.
- Patients must not have any significant medical condition which, in the judgment of the investigator, might interfere with the study or require treatment.
- Pregnant women and nursing mothers are to be excluded.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00202891
Start Date
May 1 2007
End Date
September 1 2007
Last Update
June 3 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.